BlackRock’s year-to-date stock has shown strong performance. According to Cramer, “I think you buy it. Period, end of story. I think that was an amazing quarter. That acquisition Larry Fink was really brilliant and the stock should go much higher.”Axsome Therapeutics has seen positive year-to-date stock performance. Regarding this, Cramer stated, “I don’t know it…I have to do more work because so many companies have failed when it comes to central nervous system. More work to do.”HanesBrands’ year-to-date stock performance was also mentioned during Jim Cramer’s Guide to Investing.
